Ocular implant market
Ocular Implant Market, by Implant Type (Intraocular Lenses (IOL) (Aspheric IOLs, Toric IOLs, Multifocal IOLs, Anterior chamber IOLs, and others), Corneal Implants, Glaucoma Implants, Orbital Implants, Ocular prosthesis, and others), by Application (Glaucoma Surgery, Oculoplasty, Drug Delivery, Age-Related Macular Degeneration (AMD), Aesthetic purpose, and others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
- Sep 2022
- CMI2699
- 157 Pages
- Excel & Pdf
- Medical Devices
Ocular implants are medical devices designed to replace a damaged or missing visual organ to restore vision or to improve visual appearance. Ocular implants such as ocular prostheses are artificial eyes used by people to improve facial lineaments damages due to an eye disease or trauma. Cosmetic rehabilitation for these patients through the implantation of ocular prosthesis helps in restoring the patients’ confidence by improving their external appearance. The Ocular prostheses are fitted behind the eyelids over a shrunken eyeball or an orbital implant placed following surgical removal of the eye.
Global ocular implant market is estimated to be valued at US$ 15,347.9 million in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030).
Figure 1. Global Ocular Implant Market Share (%), by Implants Type, 2022
Increasing number of product launches are expected to drive growth of the global ocular implant market.
Increasing number of product launches are expected to drive growth of the global ocular implants market. For instance, in July 2018, Alcon, an ophthalmology company had launched its intraocular lens (IOL) portfolio including, Clareon AutonoMe IOL and delivery system, designed to provide easy and intuitive control during cataract surgery, at the Alcon-hosted Synergeyes clinical symposium in Sydney. AutonoMe is the first and only automated, disposable, preloaded IOL delivery system preloaded with the Clareon IOL, and it is automated with CO2-powered delivery mechanism. Moreover, in June 2018, Molteno Ophthalmic, medical device company launched its Molteno3 S-Series glaucoma implants at the 24th Greek Glaucoma.
Ocular Implant Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2022: | US$ 15,347.9 Mn |
Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 7.3% | 2030 Value Projection: | US$ 27,018.0 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated., Morcher GmbH, OSD Medical GmbH, Ophtec BV, and ZEISS International. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Figure 2. Global Ocular Implant Market Share (%), by Region, 2022
Increasing prevalence of corneal diseases is expected to increase demand for ocular implants.
Increasing prevalence of corneal disease is expected to increase demand for ocular implants, which is expected to drive the global ocular implants market growth over the forecast period. For instance, according to the World Health Organization (WHO), corneal blindness is one of the major causes of visual deficiency after cataract, glaucoma and age-related macular degeneration (AMD) and 4th cause of blindness globally (5.1%). Moreover, according WHO, cornea diseases affect around 30 million people and around two million new cases of corneal dysfunction are diagnosed each year. Furthermore, in February 2021, according to the data published by the National Center for Biotechnology Information, prevalence of corneal diseases in globally is 217 million people and 36 million blind people, the challenge of reduced vision remains a serious public health challenge.
Global Ocular Implant Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.
However, the COVID-19 pandemic had a negative impact on the global ocular implant market, owing to the decrease in surgical procedures due to COVID 19 pandemic. For instance, in July 2020, according to the data published by the National Center for Biotechnology Information, at the procedure level, a decrease of 14.8% was observed for elective procedures and 6.0% for emergency procedures. The COVID-19 pandemic has caused substantial disruptions to surgical-care delivery mainly due to diversion of available resources from surgical to COVID-19 care, reduced flow of patients, supply-chain interruptions and social distancing and restriction measures. Surgical delivery, owing to its cross-cutting nature and synergistic effects on health systems at large, had been adversely affected by the pandemic.
Global Ocular Implant Market: Key Developments
In June 2022, EyePoint Pharmaceuticals, Inc., pSivida, Pharmaceutical Company, received Chinese regulatory body approval for an implant to treat a form of eye inflammation, becoming the first company to get a nod in the country based entirely on real-world data. Ocumension Therapeutics paid an initial $1.75 million to access EyePoint’s technology in 2018. Ocumension Therapeutics filed for National Medical Products Administration (NMPA) approval of Yutiq in April 2021. According to the biotech, the filing was the first submission for National Medical Products Administration approval of a sustained-release micro-insert with a controlled release rate of up to 36 months and the first time The positive National Medical Products Administration decision triggered a further claim, namely that Yutiq is the first medicine approved in China based entirely on real-world data. The Chinese regulator had accepted a new drug application based on real-world study data.
Global Ocular Implant Market: Restraint
The major factors that hinder growth of the global ocular implant market include stringent regulatory approvals combined with recent product recalls. For instance, in August 2018, Alcon, an ophthalmology company, had to initiate voluntary product recall of Cypass Micro-Stent device, indicated for glaucoma surgery. This was attributed to complications in endothelial loss during the use of the device.
Key Players
Major players operating in the global ocular implant market include Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated., Morcher GmbH, OSD Medical GmbH, Ophtec BV, and ZEISS International.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Implant Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technology Advancements
- Historical Overview
- Merger and Acquisition
- Regulatory Scenario
- PORTER’S Five Forces
- PEST Analysis
- Market Dynamics
- Global Ocular Implant Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
- Global Ocular Implant Market, By Implant Type, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Intraocular Lenses (IOL)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Aspheric IOLs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Toric IOLs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Multifocal IOL
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Anterior chamber IOL
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Corneal Implants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Glaucoma Implants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Orbital Implants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Ocular prosthesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Ocular Implant Market, By Application, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Glaucoma Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Oculoplasty
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Drug Delivery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Age-Related Macular Degeneration (AMD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Aesthetic purpose
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Ocular Implant Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Implant Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Implant Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Implant Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Implant Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Implant Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Implant Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Alcon (Novartis AG)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- STAAR Surgical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Johnson & Johnson Services
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- MORCHER GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bausch & Lomb Incorporated.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Carl Zeiss
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- OSD Medical GmbH,
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ophtec BV
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alcon (Novartis AG)
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 23 market data tables and 19 figures on "Global Ocular Implant Market” - forecast to 2030
Detailed Segmentation:
- Global Ocular Implants Market, By Implant Type:
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Intraocular Lenses (IOL)
- Global Ocular Implants Market, By Application:
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Others
- Global Ocular Implants Market, By Region:
- North America
- By Implant Type
- Lubiprostone
- Linaclotide
- Eluxadoline
- Rifaximin
- Alosetron
- Other
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Others
- By Country
- U.S.
- Canada
- By Implant Type
- Latin America
- By Implant Type
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Intraocular Lenses (IOL)
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Other
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Implant Type
- Europe
- By Implant Type
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Intraocular Lenses (IOL)
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Other
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Implant Type
- Asia Pacific
- By Implant Type
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Intraocular Lenses (IOL)
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Other
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Implant Type
- Middle East
- By Implant Type
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Intraocular Lenses (IOL)
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Other
- By Country
- GCC
- Israel
- Rest of Middle East
- By Implant Type
- Africa
- By Implant Type
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Intraocular Lenses (IOL)
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Other
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Implant Type
- North America